期刊文献+

左旋硝基精氨酸诱导的高血压大鼠心肌和血管的肾上腺髓质素与受体活性修饰蛋白2表达的变化 被引量:3

Changes in adrenomedullin and receptor activity-modifying protein 2 mRNA in myocardium and vessels during L-NNA-induced hypertension in rats
下载PDF
导出
摘要 探讨高血压大鼠心肌和血管的肾上腺髓质素(adrenomedullin,ADM)与受体活性修饰蛋白2(receptoractivity-modifying protein 2,RAMP2)mRNA的变化。用一氧化氮合酶(NOS)竞争性抑制剂左旋硝基精氨酸(L-NNA)阻断NOS制备大鼠高血压模型。用放射免疫分析方法测定血浆、心肌和血管ADM含量,及竞争性定量RT-PCR方法测定心肌和血管ADM mRNA与RAMP2 mRNA含量。结果表明,NOS阻断剂L-NNA应用4周后动物血压明显升高、心肌肥厚。心重(mg)/体重(g)比值增加35.5%(P<0.01)。血浆、心肌和血管的ADM-ir较对照组分别增加80%、72%和57%(均P<0.01)。高血压大鼠心肌和血管ADM mRNA含量显著增加,分别较正常大鼠高50%(P<0.05)和102.9%(P<0.05)。高血压大鼠心肌和血管的RAMP2 mRNA含量均显著增加,分别较正常大鼠高132%(P<0.01)和87%(P<0.01)。高血压大鼠心肌和血管ADM的升高与RAMP2的升高程度呈明显的正相关,其相关系数分别为0.741和0.885。上述观察结果表明,高血压时血浆、心肌和血管ADM水平升高,心肌和血管ADM与RAMP2基因表达上调,提示ADM/RAMP2系统在高血压发病中可能具有重要作用。 To explore the changes in adrenomedullin (ADM) and receptor activity-modifying protein 2 (RAMP2) mRNA in myocardium and vessels in hypertension, a hypertensive rat model was prepared by administering L-NNA. Contents of ADM in plasma, myocardium and vessels were measured by radioim-munoassay (RIA). The levels of pro-ADM mRNA of myocardium and vessels were determined by competitive quantitative RT-PCR. The results showed that L-NNA induced hypertension and cardiomegaly. The ratio of heart to body weight increased by 35. 5% (P <0. 01). In hypertensive rats die ir-ADM in plasma, myocardium and vessels was increased by 80% , 72% and 57% (P <0. 01) , respectively compared with the control. The amounts of ADM mRNA in myocardium and vessels were increased by 50% and 109. 2% (P <0. 05) , respectively, and the amounts of RAMP2 mRNA was increased by 132% and 87% (P<0. 01) , respectively, compared with control. The levels of ADM in myocardium and vessels were positively correlated with RAMP2 mRNA, the correlation coenficients were 0. 741 and 0. 885 (P < 0. 01) , respectively. The results obtained indicate that in hypertensive rats, ADM is elevated in plasma,myocardium and vessel, and ADM and RAMP2 mRNA are up-regulated in myocardium and vessel. The ADM/RAMP2 system may play an important role in the pathogenesis of hypertension.
出处 《生理学报》 CAS CSCD 北大核心 2002年第4期337-341,共5页 Acta Physiologica Sinica
基金 State Major Basic Research Development Program supported this work (No. G2000056905).
关键词 左旋硝基精氨酸 诱导 高血压 大鼠 心肌 血管 肾上腺髓质素 受体活性修饰蛋白2 hypertensive rat adrenomedullin receptor activity-modifying protein 2 mRNA
  • 相关文献

参考文献1

二级参考文献10

  • 1[1]Martinez A, Kapas S, Miller MJ, et al. Coexpression of receptors for adrenomedullin,calcitonin gene-related peptide,and amylin in pancreatic beta cells. Endocrinology, 2000, 141∶406~411.
  • 2[2]Wimalawansa SJ. Amylin,calcitonin gene-related peptide,calcitonin, and adrenomedullin: a peptide superfamily. Crit Rev Neurobiol, 1997,11∶167~239.
  • 3[3]Mclatchie LM, Fraser NJ, Main MJ, et al.RAMPs regulate the transport and ligand specifity of the calcitonin -receptor-like receptor. Nature, 1998,393∶333~339.
  • 4[4]Frayon S, Cueille C,Gnidehou S, et al. Dexamethasone increases RAMP1 and CRLR mRNA expression in human vascular smooth muscle cells. Biochem Biophys Res Commun, 2000,270∶1063~1067.
  • 5[5]Nagac T, Mukoyama M, Sugawara A, et al. Rat receptor-activity-modifying protein(RAMPs) for adrenomedullin/CGRP receptor: cloning and regulation in obstructive nephropathy. Biochem Biophys Res Commun, 2000,270∶89~93.
  • 6[6]Foord SM,Marshall FH. RAMPs: accessory proteins for seven transmembrane domain receptors.Trends Pharmacol Sci, 1999,20∶184~187.
  • 7[7]Christopoulos G, Peery KJ, Morfis M, et al. Multiple amylin receptors arise from receptor activity modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol, 1999,56∶235~242.
  • 8[8]Frash NJ, Wise A, Brown J, et al. The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor. Mol Parmacol, 1999,55∶1054~1059.
  • 9[9]Zumpe ET, Tilakaratne N, Fraser NJ, et al. Multiple ramp domain are required for generation of amylin receptor phenotype from the calcitonin receptor gene product. Biochem Biophys Res Commun, 2000,267:368~372.
  • 10[10]Oie E, Vinge LE, Yndestad A, et al. Induction of a myocardial adrenomedullin signaling system during ischemic heart failure in rats. Circulation, 2000, 101∶415~422.

共引文献10

同被引文献41

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部